Newsroom

Cancer experts call for curbs on rising drug prices

In recent years, increasingly specialized medications and an aging population that takes more drugs have substantially boosted the price of treatments for cancer, hepatitis C, cystic fibrosis and other diseases.

Read more

Doctors Object to High Cancer-Drug Prices

Amid the growing clamor, cancer medication has drawn particular ire. The average price of new cancer drugs in the U.S. increased five- to tenfold over 15 years, to more than $100,000 a year in 2012, according to the Mayo Clinic journal editorial.

Read more

Drug Companies Pushed From Far and Wide to Explain High Prices

As complaints grow about exorbitant drug prices, pharmaceutical companies are coming under pressure to disclose the development costs and profits of those medicines and the rationale for charging what they do.

Read more

PRESS STATEMENT: New Report Shows Medicare Spending Increase Driven By Specialty Drug Prices

PRESS STATEMENT: New Report Shows Medicare Spending Increase Driven By Specialty Drug Prices

Read more